Literature DB >> 3248

Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.

J P Evans, D G Grahame-Smith, A R Green, A F Tordoff.   

Abstract

1 A single electroconvulsive shock (ECS) of 150 V for 1 s increased the concentration of rat brain 5-hydroxyindoleacetic acid (5-HIAA) but did not alter brain 5-hydroxytryptamine (5-HT) or tryptophan concentrations 3 h later. 2 A single ECS decreased 5-HT synthesis 3 h and 6 h later. Synthesis was back to normal after 24 hours. The ECS-treated rats did not show greater hyperactivity produced by the increased brain 5-HT accumulation following administration of L-tryptophan and tranylcypromine at any time up to 24 h later. This suggests that a single electroshock does not alter 5-HT functional activity. 3 Twenty-four hours after the final ECS of a series of 10 shocks given once daily, the rats were given tranylcypromine and L-tryptophan. They displayed greater hyperactivity than control rats not treated with ECS, suggesting that ECS increases 5-HT functional activity. Brain concentrations of 5-HT, 5-HIAA and tryptophan were then unchanged by ECS. 5-HT synthesis and accumulation of 5-HT following tranylcypromine and L-tryptophan were not altered by ECS. 4 The hyperactivity following administration of the 5-HT agonist 5-methoxy N,N-dimethyltryptamine was enhanced by repeated (10 day) ECS, suggesting altered post-synaptic responses to 5-HT receptor stimulation. 5 Repeated ECS enhanced locomotor activity following tranylcypromine and L-DOPA. It did not alter brain noradrenaline or dopamine concentrations. 6 The latent period before a pentylenetetrazol-induced convulsion was shortened by repeated ECS. 7 Following repeated ECS there appears to be increased neuronal sensitivity to certain stimuli producing centrally mediated behavioural stimulation. This is discussed in relation to the mechanism by which electroconvulsive therapy (ECT) produces its therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 3248      PMCID: PMC1666877          DOI: 10.1111/j.1476-5381.1976.tb07442.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function.

Authors:  A R Green; D G Grahame-Smith
Journal:  Neuropharmacology       Date:  1975-02       Impact factor: 5.250

2.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

3.  Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS.

Authors:  K Modigh
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

4.  Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission.

Authors:  J Meek; K Fuxe; N E Andén
Journal:  Eur J Pharmacol       Date:  1970-03       Impact factor: 4.432

5.  In vivo measurement of brain serotonin turnover.

Authors:  N H Neff; T N Tozer
Journal:  Adv Pharmacol       Date:  1968

6.  Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain.

Authors:  G Curzon; A R Green
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

7.  Letter: Effect of chlorimipramine on the rate of tryptophan hydroxylation in the intact and transected spinal cord.

Authors:  K Modigh
Journal:  J Pharm Pharmacol       Date:  1973-11       Impact factor: 3.765

8.  The determination of tryptophan in plasma, liver, and urine.

Authors:  W D Denckla; H K Dewey
Journal:  J Lab Clin Med       Date:  1967-01

9.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

10.  Serotonin release from brain slices by electrical stimulation: regional differences and effect of LSD.

Authors:  T N Chase; G R Breese; I J Kopin
Journal:  Science       Date:  1967-09-22       Impact factor: 47.728

View more
  35 in total

1.  Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy.

Authors:  D W Costain; A R Green; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

2.  Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.

Authors:  A R Green; D J Heal; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

Review 3.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens.

Authors:  G G Nomikos; A P Zis; G Damsma; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Reactivity of the dopa-dopamine-noradrenaline-adrenaline system in epileptic patients.

Authors:  V A Karlov; M A Gleiser
Journal:  Neurosci Behav Physiol       Date:  1986 Jan-Feb

6.  Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat.

Authors:  P Blier; C de Montigny; D Tardif
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT.

Authors:  J R McWilliam; B S Meldrum; S A Checkley
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.

Authors:  P J Cowen; D G Grahame-Smith; A R Green; D J Heal
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

9.  Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.

Authors:  A Reches; H R Wagner; A I Barkai; V Jackson; E Yablonskaya-Alter; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.

Authors:  A I Barkai; S Kowalik; A Reches
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.